Yicha - Eisai starts trials for a second Alzheimer's drug a day after Biogen failure wiped $18B off its value

Article: https://www.cnbc.com/2019/03/22/eisai-starts-phase-3-trials-for-second-alzheimers-drug-after-firsts-failure.html